JORPOVI Trademark

Trademark Overview


On Wednesday, November 21, 2018, a trademark application was filed for JORPOVI with the United States Patent and Trademark Office. The USPTO has given the JORPOVI trademark a serial number of 79260628. The federal status of this trademark filing is REGISTERED as of Tuesday, April 28, 2020. This trademark is owned by Bio-Thera Solutions, Ltd.. The JORPOVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in humans for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases
jorpovi

General Information


Serial Number79260628
Word MarkJORPOVI
Filing DateWednesday, November 21, 2018
Status700 - REGISTERED
Status DateTuesday, April 28, 2020
Registration Number6039321
Registration DateTuesday, April 28, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in humans for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBio-Thera Solutions, Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressScience City, Guangzhou Guangdong
CN

Party NameBio-Thera Solutions, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressScience City, Guangzhou Guangdong
CN

Party NameBio-Thera Solutions, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressScience City, Guangzhou Guangdong
CN

Trademark Events


Event DateEvent Description
Saturday, September 26, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 7, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 4, 2020FINAL DISPOSITION PROCESSED
Tuesday, July 28, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 28, 2020REGISTERED-PRINCIPAL REGISTER
Friday, February 14, 2020NOTIFICATION PROCESSED BY IB
Tuesday, February 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 29, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 6, 2020EXAMINER'S AMENDMENT ENTERED
Monday, January 6, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 6, 2020EXAMINERS AMENDMENT E-MAILED
Monday, January 6, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019ASSIGNED TO LIE
Tuesday, December 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 2, 2019REFUSAL PROCESSED BY IB
Friday, July 12, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 12, 2019REFUSAL PROCESSED BY MPU
Monday, June 24, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, June 23, 2019NON-FINAL ACTION WRITTEN
Saturday, June 22, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, June 18, 2019ASSIGNED TO EXAMINER
Tuesday, June 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 13, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB